RegOpsPro™

MHRA GDP Inspection Intelligence

Understand published MHRA inspection activity, identify the GDP controls worth challenging and carry out a practical evidence-led readiness check.

How active is MHRA GDP inspection oversight?

Routine GDP inspections remain a regular part of MHRA oversight. The published annual figures below provide a view of inspection activity, rather than the likelihood of an individual licence holder being inspected or receiving a deficiency.

What this means for you: Maintain inspection readiness as a routine operating discipline. Ensure that key decisions, evidence and responsible-person oversight can be demonstrated without relying on last-minute preparation.

Inspection activity data and sources

The figures show routine inspections by MHRA financial year. The 2025–26 total was 22.4% higher than in 2024–25; inspection volume alone does not establish changes in compliance performance.

MHRA annual report 2023–24 · 2024–25 · 2025–26

What can we learn from MHRA inspection findings?

MHRA's published symposium information highlights the importance of quality governance, distribution controls and demonstrable oversight. Historical deficiency findings can help you challenge your systems, but they are not a ranking of today's inspection risks.

Published deficiency overview

473 inspections and 1,189 recorded deficiencies were included in the MHRA's October 2021–November 2022 analysis, discussed at the 2023 GDP Symposium.

This is a historical reporting period, not a current deficiency rate.

Where to focus your challenge

Use the published themes to examine quality management, transport, customer qualification, returns and RP oversight. The specific percentages available from the 2018 symposium relate to that earlier dataset and should not be treated as current prevalence.

What this means for you: Do not simply ask whether a procedure exists. Ask whether the control operates effectively, whether evidence is retrievable and whether decisions and follow-up can be demonstrated.

View historical deficiency figures and methodology

At the 2018 GDP Symposium, MHRA reported the following categories within its stated major and non-IAG-referred critical finding dataset. Categories may overlap; percentages are not a current UK benchmark.

Quality management38%
Transport25%
Customer qualification20%
Returned medicinal products18%
Responsible Person15%

MHRA 2018 symposium summary · MHRA 2023 symposium summary. The 2023 summary does not provide a numerical breakdown of its five most common deficiency categories.

Further historical MHRA deficiency information

For a more detailed historical view, see the MHRA's 2016 GDP deficiency report. It covers a sample of 148 inspections from the 1,428 conducted that year. Findings from this sample should not be used as current UK deficiency rates or predictive benchmarks.

What should you challenge in your GDP operation?

Use inspection intelligence to test whether controls work in practice across the six RegOpsPro GDP control layers. Start with a recent example, follow the evidence and check that ownership and follow-up are clear.

Governance & accountability

Can you trace a significant GDP decision to the accountable person and its supporting rationale?

Suppliers & outsourced controls

Are qualification, ongoing monitoring and outsourced responsibilities evidenced and current?

Product & distribution control

Can you demonstrate storage, transport, returns and traceability controls through actual records?

Risk, events & CAPA

Do deviations, security incidents and excursions lead to proportionate decisions and verified follow-up?

Assurance & inspection readiness

Can you retrieve records, explain gaps and show that self-inspection findings drive improvement?

Leadership visibility

Does management receive meaningful oversight of recurring risks, overdue actions and control effectiveness?

Practical next step: Select one control layer below and test a real recent record. Where evidence is incomplete, record the gap and decide what follow-up is needed.

Further MHRA inspectorate perspectives

In its 2023 GDP Symposium summary, MHRA discussed licence-wide oversight, short-notice and unannounced inspections, supply-chain security and adverse weather or temperature risks. These are published inspectorate perspectives, not a quantified ranking of current findings.

Read the MHRA symposium summary.

Challenge your GDP controls

Use the separate 14-question MHRA GDP Inspection Self-Check to explore whether controls and evidence can withstand inspection challenge. For a broader scored assessment, use the Inspection Readiness Scorecard.